Description

Filstim (Filgrastim) Solution for Injections 0.3 mg. 1ml. (30 ml. n.ME) №1 Vial

Ingredients:

Each vial contains 0.3 mg of Filgrastim as the active ingredient. Other ingredients include mannitol, polysorbate 80, and sodium.

Dosage:

The recommended dosage of Filstim injection is determined by a healthcare professional based on the patient’s condition. It is typically administered subcutaneously or intravenously.

Indications:

Filstim is indicated for the treatment of neutropenia, a condition characterized by a low level of white blood cells. It is commonly used in cancer patients undergoing chemotherapy to reduce the risk of infection.

Contraindications:

Do not use Filstim if you are allergic to Filgrastim or any of the other ingredients in the solution. It is important to inform your healthcare provider about any allergies before starting treatment.

Directions:

Follow the instructions provided by your healthcare provider for the correct administration of Filstim. It is important to not self-administer this medication unless instructed to do so.

Scientific Evidence:

Filgrastim, the active ingredient in Filstim, works by stimulating the bone marrow to produce more white blood cells, thereby reducing the risk of infections in patients undergoing chemotherapy. Clinical trials have shown that Filgrastim is effective in reducing the duration and severity of neutropenia in cancer patients.

Research published in the Journal of Clinical Oncology has demonstrated the efficacy of Filgrastim in improving neutrophil counts and reducing the incidence of febrile neutropenia in cancer patients receiving myelosuppressive chemotherapy.

Additional Information:

• Storage: Store Filstim in the refrigerator at 2°C to 8°C. Do not freeze.
• Side Effects: Common side effects may include bone pain, headache, and fatigue. Contact your healthcare provider if you experience severe side effects.